<DOC>
	<DOCNO>NCT00320671</DOCNO>
	<brief_summary>This 52 week long study evaluate effectiveness aripiprazole versus risperidone treat people first-episode schizophrenia . Patients improve medication receive clozapine third medication trial .</brief_summary>
	<brief_title>Comparison Aripiprazole Risperidone Treatment People With First-Episode Psychosis</brief_title>
	<detailed_description>Schizophrenia severely disable brain disorder . People schizophrenia often experience hallucination , delusion , think disorder , movement disorder . Medications available alleviate symptom schizophrenia , many cause undesirable side effect . For example , two early second generation antipsychotic , olanzapine risperidone , show effective treat schizophrenia symptom , cause rapid , substantial weight gain . There low risk side effect newer second generation antipsychotic , aripiprazole . Little known , however , effectiveness new medication treat people first-episode schizophrenia . This study evaluate effectiveness aripiprazole versus risperidone treatment first-episode schizophrenia . Participants double-blind study randomly assign receive either aripiprazole risperidone 12 week . Subjects meet response criterion continue initial blind antipsychotic additional 4 week total length 16 week treatment . Subjects meet response criterion week 16 continue successful blind medication remain time study . Patients respond treat medication ( aripiprazole risperidone ) receive first 16 week study . The second antipsychotic trial last 16 week . Patients respond switch phase continue successful medication remain time study . Patients respond second medication trial treat open-label clozapine 20 week . Safety monitor clozapine-treated subject follow establish procedure multi-episode patient ( e.g . weekly complete blood count ( CBC ) monitoring ) . The total length patient participation 52 week . During longitudinal follow-up phase , subject may prescribe open-label sodium valproate manic symptom open-label sertraline symptom depression anxiety empirically responsive ( Selective serotonin reuptake inhibitor ) SSRI treatment . Additionally , participant take part Healthy Lifestyles program aim prevent weight gain . The Healthy Lifestyles program provide psycho-education , supportive psychotherapy , medication adherence counseling . At visit , treatment metabolic outcome assess . Participants meet psychiatrist , evaluate progress medication dosage , social worker , administer Healthy Lifestyles Program . Upon completion study , participant receive follow-up care clinical staff member part research team . For information relate study , please follow link : http : //clinicaltrials.gov/show/NCT00000374</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Current Diagnostic Statistical Manual Mental Disorders ( DSMIV ) diagnosis schizophrenia , schizophreniform disorder , schizoaffective disorder , similar psychotic disorder otherwise specify , assess use Structured Clinical Interview Axis I DSMIV Disorders ( SCIDI/P ) History previous antipsychotic medication treatment duration 2 week less Current positive symptom rat 4 ( moderate ) one follow Brief Psychiatric Rating Scale ( BPRSA ) item : conceptual disorganization ; grandiosity ; hallucinatory behavior ; unusual thought content Agrees use effective form contraception Any serious neurological endocrine disorder , medical condition treatment know affect brain Any current medical condition require treatment medication psychotropic effect At significant risk suicidal homicidal behavior Cognitive language limitation , factor would interfere participant 's ability provide inform consent safely participate study procedure Diagnosis diabetes , define fast plasma glucose level least 126 mg/dL , metabolic syndrome , define three follow : high blood pressure ( great 135/85 mmHg ) ; truncal obesity ( waist circumference great 40 inch men great 35 inch woman ) ; elevate fast glucose ( great 110 mg/dL ) ; low HDLcholesterol ( less 40 mg/dL men le 50 mg/dL woman ) ; elevate triglyceride ( define great 150 mg/dL ) Requires treatment antidepressant mood stabilize medication Meets DSMIV criterion current substanceinduced psychotic disorder , psychotic disorder due general medical condition , delusional disorder , brief psychotic disorder , share psychotic disorder , mood disorder ( major depression bipolar ) psychotic feature Any medical condition would make treatment risperidone aripiprazole medically inadvisable</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>First-episode</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Schizophreniform Disorder</keyword>
	<keyword>Psychotic Disorder Not Otherwise Specified NOS</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>Clozapine</keyword>
	<keyword>Risperidone</keyword>
</DOC>